News in Brief Medicine // Silver Is Damaging To Human Fibroblasts © Based on Material by UDE, Germany
Silver, an element long favored by medicine for its antiseptic properties, turns out to be damaging to human fibroblasts when used in the dosages required to be effective. Furthermore, the presence of albumin weakens silver’s ability to fight bacteria. These findings were recently made by a team of researchers working under the direction of Dr. Stephan Barcikowski, a professor with the Center for Nanointegration (CENIDE) at University of Duisburg-Essen (UDE), Germany.
The team conducted a series of tests examining the antibacterial activities of silver nanoparticles that the researchers produced themselves using laser technology. The scientists bound the nanoparticles to various synthetic materials so that they would not be absorbed by the body but would remain effective, because their large surfaces emit enough silver ions. It is these ions that are, in fact, the active substances that, for example, kill bacteria at a wound, reducing the risk for infection. Silver is therefore a substance well-suited for preserving medical products or for covering burn wounds.
Experiments using various bacteria conducted in collaboration with the clinic at the Hannover Medical School under the direction of Dr. Meike Stiesch confirmed silver’s germicidal properties. Subsequent studies, however, demonstrated that at the concentrations required for killing bacteria, the silver ions also damaged fibroblasts to a significant degree. "We hadn’t expected this to be the case, of course, given that silver is already widely used throughout medicine," said Barcikowski, Chair of Technical Chemistry I at the UDE and editor-in-chief of the journal BioNanoMaterials. "But further testing proved that it was the ions themselves that were damaging the cells and not, as we had at first suspected, the synthetic materials." When the scientists then mixed the samples with albumin, silver’s antibacterial effectiveness dropped, but the damaging effect on the cells remained the same. The therapeutic margin is therefore extremely narrow in this case, making medical applications risky.
Further studies are currently investigating whether it is possible to use the wound-healing properties of nanomaterials in a targeted manner. The study, "In-situ conjugation of nanoparticles using ultra-short pulsed laser ablation in monomer solution for electrospinning at burn wound sites," which is part of the DFG Priority Program 1327 "Sub-100 nm Structures," is currently looking into this. In collaboration with RWTH Aachen University and the Hannover Medical School, a team is researching whether nanoparticles composed of milder substances, such as zinc, iron, and magnesium, can be used to heal burn wounds. The researchers would like to test less harmful nanomaterials and then make them usable for therapeutic purposes.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93